U.S. market Closed. Opens in 17 hours 6 minutes

HALO | Halozyme Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
Revenue829.25M660.12M443.31M267.59M195.99M151.86M316.61M146.69M135.06M75.33M54.80M42.33M56.09M13.62M13.67M8.76M3.80M981.75K127.21KN/A25.70K87.77K24.68K
Cost of Revenue192.36M139.30M81.41M43.37M45.55M10.14M31.15M33.21M29.25M22.73M6.25M1.09M257.83K985.28K311.89K332.32K240.43K436.99K51.97KN/A27.00K49.67K15.86K
Gross Profit636.89M520.81M361.90M224.23M150.45M141.73M285.46M113.48M105.81M52.60M48.55M41.23M55.83M12.64M13.36M8.43M3.56M544.76K75.24KN/A-1.30K38.09K8.83K
Operating Expenses299.32M253.28M86.00M79.97M218.06M211.06M204.46M196.69M133.26M115.64M128.99M94.86M75.67M66.90M71.82M58.87M31.71M16.13M13.64M9.09M77.79K77.48K48.53K
Selling, General & Admin149.18M143.53M50.32M45.74M77.25M60.80M53.82M45.85M40.03M35.94M32.35M24.81M18.10M15.12M15.20M14.63M11.16M6.91M3.42M2.57M77.79K350.0048.53K
Research & Development76.36M66.61M35.67M34.24M140.80M150.25M150.64M150.84M93.24M79.70M96.64M70.04M57.56M51.77M56.61M44.23M20.55M9.21M10.22M6.52MN/AN/AN/A
Other Operating Expenses73.77M43.15MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A77.13KN/A
Operating Income337.57M267.53M275.90M144.25M-67.61M-69.33M81.00M-83.21M-27.45M-63.04M-80.43M-53.63M-19.84M-54.26M-58.46M-50.43M-28.15M-15.58M-13.56M-9.09M-79.09K-39.39K-39.71K
Other Expenses / Income29.52M-18.61M-27.38M-14.95M-4.64M7.58M-19.39M-18.65M-4.78M-5.34M-3.04M73.44K5.56K1.02M97.74K1.72MN/AN/A286.04K-3.53KN/A-25.08K54.00
Before Tax Income348.33M248.92M248.52M129.30M-72.25M-79.79M61.61M-101.86M-32.23M-68.38M-83.48M-53.55MN/A-53.24M-58.36M-48.72MN/AN/A-13.28MN/AN/A-64.46K-39.65K
Income Tax Expenses66.73M46.79M-154.19M217.00K-11.00K537.00K-1.36M1.16MN/AN/AN/AN/AN/AN/AN/A-63.00KN/AN/AN/AN/AN/A800.00N/A
Net Income281.59M202.13M402.71M129.09M-72.24M-80.33M62.97M-103.02M-32.23M-68.38M-83.48M-53.55M-19.77M-53.24M-58.36M-48.65M-23.90M-14.75M-13.28M-9.09M-79.09K-65.26K-39.65K
Interest Expenses18.76M16.95M7.53M20.38M11.63M18.04M21.98M19.98M5.20M5.58M3.27MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding131.93M136.84M140.65M136.21M144.33M143.60M136.42M127.96M126.70M122.69M112.81M111.08M102.57M94.36M86.70M79.84M74.32M62.61M50.32M35.41M8.20M1.69M1.20M
Diluted Shares Outstanding134.20M140.61M146.80M141.46M144.33M143.60M139.07M127.96M126.70M122.69M112.81M111.08M102.57M94.36M86.70M79.84M74.32M62.61M50.32M35.41M8.20M1.69M1.20M
EBITDA422.43M310.68M275.90M144.25M-67.61M-69.33M85.75M-79.47M-25.35M-61.03M-78.98M-52.47M-18.67M-51.73M-56.92M-47.67M-23.32M-14.51M-13.07M-8.96M-79.09K-64.46K-39.65K
EBITDA Margin50.94%47.06%62.24%53.91%-34.50%-45.65%27.09%-54.18%-18.77%-81.02%-144.12%-123.97%-33.30%-379.72%-416.32%-543.91%-613.75%-1,477.77%-10,273.66%0.00%-307.69%-73.45%-160.63%
EBIT367.09M265.87M256.04M149.68M-60.62M-61.75M83.59M-81.88M-27.03M-62.79M-80.20M-53.55M-19.77M-53.24M-58.36M-48.72M-23.90M-14.75M-13.28M-9.09M-79.09K-64.46K-39.65K
EBIT Margin44.27%40.28%57.76%55.94%-30.93%-40.66%26.40%-55.82%-20.01%-83.35%-146.36%-126.53%-35.25%-390.79%-426.88%-555.87%-628.93%-1,502.63%-10,435.88%0.00%-307.69%-73.45%-160.63%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙